Physician profile
John M Pendleton
NPI 1053638700
$12,103.63
in general payments reported to CMS, 2019-2025
22 companies · $36.61 in 2025
The $36.61 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,919 · 2020: $865 · 2021: $2,895 · 2022: $1,518 · 2023: $4,502 · 2024: $368 · 2025: $36.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,754 · Food and Beverage: $1,136 · Education: $1,000 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,754.02 |
| Food and Beverage | $1,135.68 |
| Education | $1,000.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,973.19 | 2019-2024 | Da Vinci Surgical System, Davinci Xi |
| Davol INC. | $740.19 | 2020-2023 | Phasix Mesh |
| Stryker Corporation | $586.44 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $117.69 | 2021-2023 | Exparel |
| Endogastric Solutions, INC | $112.00 | 2021 | |
| Covidien Lp | $80.78 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $58.91 | 2024-2025 | |
| Medtronic, INC. | $57.41 | 2022 | |
| Ethicon US, LLC | $53.82 | 2023-2024 | Enseal |
| Kerecis Limited | $47.80 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Karl Storz Endoscopy-America | $47.65 | 2019 | |
| Tela Bio, INC. | $35.03 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.83 | 2023 | Gattex |
| Avita Medical Americas, LLC | $26.01 | 2024 | |
| Allergan, INC. | $25.33 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.80 | 2024 | Renasys Touch, Pico 7, Pico 14 |
| Blue Earth Diagnostics | $17.63 | 2019 | |
| Endomagnetics Ltd | $17.27 | 2022 | |
| Abbvie INC. | $16.74 | 2022 | |
| Axonics, INC. | $14.49 | 2023 | Axonics |
| Polynovo North America LLC | $14.08 | 2024 | Novosorb Btm |
| Boston Scientific Corporation | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pendleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.